Actinium Pharmaceuticals, Inc. announced the appointment of Rowena Choudrie, M.S. to the position of Senior Director, Pharmaceutical Product Development. Choudrie will report to Kaushik J. Dave, Ph.D., MBA Chief Executive Officer and Felix Garzon, M.D., Ph.D., Senior Vice President, Head of Clinical Development, respectively. Ms. Choudrie has over 20 years of pharmaceutical industry experience with roles of increasing responsibility in product development.

At Actinium, Ms. Choudrie will be responsible for clinical trial material supply, drug product process scale-up to support commercial supply and final product formulation. In addition, she will support Actinium's regulatory efforts particularly in the area of Chemistry, Manufacturing and Control (CMC). Most Recently, Ms. Choudrie worked at NPS Pharmaceuticals as Senior Director, Pharmaceutical Development, Global Technical Operations where she directed formulation development, process development and clinical manufacturing while managing Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs).